01 / 20

Inflammatory Bowel Disease
Longitudinal Care

Managing Crohn disease and ulcerative colitis over time: induction, maintenance, monitoring, and surveillance.

USMLE Step 3

What Is IBD?

Inflammatory bowel disease is a group of chronic, relapsing-remitting immune-mediated disorders of the gastrointestinal tract. The two main forms are Crohn disease (CD) and ulcerative colitis (UC).

Crohn Disease
Transmural inflammation, skip lesions, anywhere mouth to anus. Fistulas and strictures common.
Ulcerative Colitis
Mucosal inflammation, continuous, limited to colon and rectum. Bloody diarrhea typical.

The Relapsing-Remitting Course

High Low Time Disease Activity Remission goal Flare Flare

Two Phases: Induction & Maintenance

Induction
Goal: rapidly stop active inflammation. Uses corticosteroids (oral/IV), biologics, or aminosalicylates for a flare.
Maintenance
Goal: keep remission long-term. Uses thiopurines, methotrexate, biologics, or 5-ASA. Steroids are NOT for maintenance.

The Treatment Ladder

Surgery / Biologics Immunomodulators (azathioprine, MTX) Corticosteroids (induction) 5-ASA (UC), lifestyle Higher potency First line

Core Rule: Treat-to-Target

Don't just treat symptoms. Set objective targets and adjust therapy until they're met. Targets are checked at intervals using a composite of measures:

1
Clinical remission: resolution of diarrhea, bleeding, and abdominal pain.
2
Biomarker normalization: normal CRP and fecal calprotectin.
3
Endoscopic healing: mucosal healing on colonoscopy, the strongest predictor of long-term outcome.

Distinction: CD vs UC

Crohn Disease Ulcerative Colitis
LocationMouth to anus, skip lesionsColon only, continuous
DepthTransmuralMucosa / submucosa
ComplicationsFistulas, strictures, abscessToxic megacolon, dysplasia
SmokingWorsens diseaseParadoxically protective
Cure by surgeryNo (recurs)Yes (colectomy)
5-ASA roleLimitedMainstay for mild-moderate

Drug Safety Monitoring

Thiopurines
Check TPMT before starting. Monitor CBC (leukopenia) and LFTs. Lymphoma and skin cancer risk.
Anti-TNF biologics
Screen for latent TB and hepatitis B before starting. Risk of reactivation and serious infection.
Corticosteroids
Bone density, glucose, BP monitoring. Avoid chronic use; add calcium/vitamin D.

A Step-by-Step Approach

1
Assess activity. Use symptoms + CRP + fecal calprotectin; endoscopy if uncertain.
2
Induce remission for active flares (steroids/biologics), then transition off steroids.
3
Maintain remission with a steroid-sparing agent matched to disease severity.
4
Monitor safety labs and screen for drug toxicity at regular intervals.
5
Screen for complications: surveillance colonoscopy, bone health, mental health, nutrition.

Worked Example: Steroid Dependence

A 28-year-old with ileal Crohn disease flares each time prednisone is tapered below 15 mg. He has had 3 flares in the past year while on 5-ASA only.

Worked Example: Surveillance

A 45-year-old has had extensive ulcerative colitis for 9 years, currently in remission. She asks how often she needs colonoscopy.

Dx Year 0 Baseline scope ~8 yrs Repeat q1-3 yrs Ongoing

Worked Example: Acute Severe Flare

A 22-year-old with UC has 10 bloody stools/day, fever, tachycardia, and abdominal distension. CRP is markedly elevated.

Longitudinal Health Maintenance

Bone Health
DEXA scan with steroid exposure; calcium and vitamin D supplementation.
Vaccines
Annual influenza, pneumococcal, HBV; live vaccines before immunosuppression.
Skin / Nutrition
Annual derm exam (thiopurines), B12 with ileal disease, iron for anemia.

Common Mistakes

✕ Steroids for maintenance
Steroids induce but never maintain. Chronic use causes serious toxicity.
✕ Skipping pre-biologic screening
Forgetting TB/HBV screening risks reactivation when starting anti-TNF.
✕ Treating symptoms only
Ignoring biomarkers and mucosal healing leads to silent bowel damage.
✕ Opioids in severe flare
Antidiarrheals/opioids can precipitate toxic megacolon in acute severe colitis.

Summary: Drug Roles

Agent Induction Maintenance
CorticosteroidsYesNo
5-ASA (UC)Yes (mild)Yes (UC)
ThiopurinesSlow onsetYes
Anti-TNF biologicsYesYes
MethotrexateYes (CD)Yes (CD)

Question 1 of 5

A 30-year-old with Crohn disease has flared 3 times this year, each requiring prednisone, and cannot taper below 20 mg without relapse. What is the most appropriate next step?

Question 2 of 5

Before initiating an anti-TNF biologic such as infliximab, which screening is most essential?

Question 3 of 5

A patient with extensive ulcerative colitis was diagnosed 8 years ago and is in remission. What surveillance is recommended?

Question 4 of 5

A 22-year-old with UC is admitted with 12 bloody stools/day, fever, and abdominal distension. Which order should be avoided?

Question 5 of 5

In a treat-to-target strategy for IBD, which finding best confirms an optimal treatment response?